Larry Yet

2.6k total citations · 1 hit paper
29 papers, 1.9k citations indexed

About

Larry Yet is a scholar working on Organic Chemistry, Molecular Biology and Cancer Research. According to data from OpenAlex, Larry Yet has authored 29 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Organic Chemistry, 12 papers in Molecular Biology and 5 papers in Cancer Research. Recurrent topics in Larry Yet's work include Asymmetric Synthesis and Catalysis (9 papers), Synthetic Organic Chemistry Methods (5 papers) and Catalytic Cross-Coupling Reactions (4 papers). Larry Yet is often cited by papers focused on Asymmetric Synthesis and Catalysis (9 papers), Synthetic Organic Chemistry Methods (5 papers) and Catalytic Cross-Coupling Reactions (4 papers). Larry Yet collaborates with scholars based in United States, Sweden and Canada. Larry Yet's co-authors include Douglass F. Taber, Guangwu Chen, Robert F. Campbell, Kristina Nilsson, Tord Inghardt, Harold Shechter, Dennis Otali, Verónica Ramírez‐Alcántara, Alexandra M. Fajardo and Evrim Gurpinar and has published in prestigious journals such as Chemical Reviews, Angewandte Chemie International Edition and Journal of Clinical Oncology.

In The Last Decade

Larry Yet

29 papers receiving 1.8k citations

Hit Papers

Metal-Mediated Synthesis of Medium-Sized Rings 2000 2026 2008 2017 2000 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Larry Yet United States 14 1.6k 436 221 97 93 29 1.9k
Takumichi Sugihara Japan 24 1.7k 1.1× 466 1.1× 222 1.0× 109 1.1× 46 0.5× 78 2.0k
Ludmila Ermolenko France 24 1.8k 1.1× 459 1.1× 217 1.0× 89 0.9× 39 0.4× 43 2.0k
Shaozhong Wang China 25 2.3k 1.4× 253 0.6× 285 1.3× 94 1.0× 66 0.7× 89 2.4k
Tomomi Kawasaki Japan 27 2.3k 1.4× 473 1.1× 248 1.1× 131 1.4× 141 1.5× 86 2.5k
Valeria Di Bussolo Italy 23 1.2k 0.7× 734 1.7× 135 0.6× 46 0.5× 72 0.8× 108 1.5k
Michael J. Martinelli United States 21 1.2k 0.7× 454 1.0× 126 0.6× 153 1.6× 39 0.4× 54 1.5k
Ian S. Young United States 14 1.9k 1.2× 428 1.0× 180 0.8× 123 1.3× 44 0.5× 24 2.1k
Chad A. Lewis United States 18 1.1k 0.7× 582 1.3× 229 1.0× 204 2.1× 35 0.4× 32 1.4k
Cristina Cimarelli Italy 22 1.3k 0.8× 474 1.1× 185 0.8× 50 0.5× 38 0.4× 68 1.5k
Gianni Palmieri Italy 23 1.7k 1.1× 588 1.3× 278 1.3× 63 0.6× 50 0.5× 63 1.9k

Countries citing papers authored by Larry Yet

Since Specialization
Citations

This map shows the geographic impact of Larry Yet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Larry Yet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Larry Yet more than expected).

Fields of papers citing papers by Larry Yet

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Larry Yet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Larry Yet. The network helps show where Larry Yet may publish in the future.

Co-authorship network of co-authors of Larry Yet

This figure shows the co-authorship network connecting the top 25 collaborators of Larry Yet. A scholar is included among the top collaborators of Larry Yet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Larry Yet. Larry Yet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Sun, Jianping, et al.. (2022). Multi-Substituted Quinolines as HIV-1 Integrase Allosteric Inhibitors. Viruses. 14(7). 1466–1466. 5 indexed citations
3.
Yet, Larry, et al.. (2021). Synthesis of 3-aryl-1-phosphinoimidazo[1,5-a]pyridine ligands for use in Suzuki–Miyaura cross-coupling reactions. RSC Advances. 11(45). 28347–28351. 4 indexed citations
4.
Yet, Larry, et al.. (2019). Synthesis of 3-aryl-2-phosphinoimidazo[1,2-a]pyridine ligands for use in palladium-catalyzed cross-coupling reactions. RSC Advances. 9(31). 17778–17782. 5 indexed citations
5.
Yet, Larry. (2018). Privileged Structures in Drug Discovery. 90 indexed citations
6.
Zhu, Bing, Nan Li, Kevin Lee, et al.. (2017). Phosphodiesterase 10A is overexpressed in lung tumor cells and inhibitors selectively suppress growth by blocking β-catenin and MAPK signaling. Oncotarget. 8(41). 69264–69280. 34 indexed citations
7.
Chattopadhyay, Debasish, Mark R. Swingle, E. Alan Salter, et al.. (2016). Crystal structures and mutagenesis of PPP-family ser/thr protein phosphatases elucidate the selectivity of cantharidin and novel norcantharidin-based inhibitors of PP5C. Biochemical Pharmacology. 109. 14–26. 25 indexed citations
8.
Seganish, W. Michael, William T. McElroy, R. Jason Herr, et al.. (2015). Initial optimization and series evolution of diaminopyrimidine inhibitors of interleukin-1 receptor associated kinase 4. Bioorganic & Medicinal Chemistry Letters. 25(16). 3203–3207. 7 indexed citations
9.
McElroy, William T., W. Michael Seganish, R. Jason Herr, et al.. (2015). Discovery and hit-to-lead optimization of 2,6-diaminopyrimidine inhibitors of interleukin-1 receptor-associated kinase 4. Bioorganic & Medicinal Chemistry Letters. 25(9). 1836–1841. 13 indexed citations
10.
Yet, Larry, et al.. (2015). Progress in the development of fatty acid synthase inhibitors as anticancer targets. Bioorganic & Medicinal Chemistry Letters. 25(20). 4363–4369. 68 indexed citations
11.
Yet, Larry, et al.. (2015). ChemInform Abstract: Progress in the Development of Fatty Acid Synthase Inhibitors as Anticancer Targets. ChemInform. 46(48). 1 indexed citations
12.
Guo, Cheng, Peter R. Guzzo, Mark Hadden, et al.. (2010). Synthesis of 7-benzyl-5-(piperidin-1-yl)-6,7,8,9-tetrahydro-3H-pyrazolo[3,4-c][2,7]naphthyridin-1-ylamine and its analogs as bombesin receptor subtype-3 agonists. Bioorganic & Medicinal Chemistry Letters. 20(9). 2785–2789. 12 indexed citations
13.
Yet, Larry. (2004). Five‐Membered Ring Systems with More than One N Atom. ChemInform. 35(50). 1 indexed citations
14.
Campbell, Robert F., et al.. (2003). Enzymatic resolution of substituted mandelic acids. Tetrahedron Letters. 44(29). 5477–5481. 26 indexed citations
15.
Yet, Larry. (2003). Chemistry and Biology of Salicylihalamide A and Related Compounds. Chemical Reviews. 103(11). 4283–4306. 220 indexed citations
16.
Yet, Larry. (2001). Recent Developments in Catalytic Asymmetric Strecker-Type Reactions. Angewandte Chemie International Edition. 40(5). 875–877. 1 indexed citations
17.
Yet, Larry. (2001). Recent Developments in Catalytic Asymmetric Strecker-Type Reactions. Angewandte Chemie International Edition. 40(5). 875–877. 229 indexed citations
18.
Yet, Larry. (2001). Neue Entwicklungen bei der katalytisch‐asymmetrischen Strecker‐Reaktion. Angewandte Chemie. 113(5). 900–902. 62 indexed citations
19.
Yet, Larry. (1999). Free radicals in the synthesis of medium-sized rings. Tetrahedron. 55(31). 9349–9403. 176 indexed citations
20.
Taber, Douglass F., et al.. (1995). Conversion of phenyldimethylsilyl to the hydroxyl in the presence of a carbon-carbon double bond. Tetrahedron Letters. 36(3). 351–354. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026